for Multiple Sclerosis
A 2-Day Pre-Conference CME Program in Conjunction with ACTRIMS Forum 2017
Course Chair: Fred Lublin, MD
The Advanced Curriculum for Multiple Sclerosis is designed to introduce neurologists to “sub-specialty” status for the care of patients with multiple sclerosis. Over the last several years, the scientific advances in pathophysiology and therapeutic options in the field of multiple sclerosis have exponentially progressed to a level of complexity, such that many standard educational formats have become limited. This CME activity is designed to fill the professional gaps of community neurologists to make their skills more aligned with those neurologists working at a multiple sclerosis center.
Neurologists, and other clinicians responsible for the care of patients with multiple sclerosis.
$149 Regular Registration Close…………….February 22nd
$199 On-site Registration Open……………..February 22nd
AcademicCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
AcademicCME designates this activity for a maximum of 13.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Americans with Disabilities Act
Event Staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact us prior to the live event by emailing requests to email@example.com.
Americas Committee for Treatment & Research in Multiple Sclerosis (ACTRIMS) is excited to announce the second annual ACTRIMS Forum at the Omni ChampionsGate in Orlando, Fla., February 23 – 25, 2017.
Themed “Environmental Factors, Genetics, and Epigenetics in MS Susceptibility and Clinical Course,” this highly anticipated CME accredited meeting stands apart from many traditional medical conferences by offering a singular track of talks focused on cutting edge topics in MS research, in a highly interactive environment. ACTRIMS Forum 2017 promises to be of value to physicians, scientists, researchers, analysts, faculty, fellows and allied health professionals examining the advances in research and treatment of MS on the care of patients.
For more information, please visit: www.actrims.org/forum2017